
Zolpidem
Zolpidem is a short-acting sleep medicine for short-term insomnia. Trials and meta-analyses show it helps people fall asleep faster than placebo, by about 22 minutes on sleep studies across Z-drugs, with more dropouts for side effects. Its boxed warning covers complex sleep behaviors, and alcohol must be avoided on any night it is taken.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with insomnia, mainly trouble falling asleep, who need short-term treatment from a prescriber
Common dosing range
Set by a prescriber. For Ambien the label starts at 5 mg for women and 5 or 10 mg for men, once a night immediately before bed with 7 to 8 hours left for sleep; never more than 10 mg a night. Older adults and people with mild to moderate liver impairment take 5 mg
When to expect effects
Works the same night; in label studies blood levels peaked about 1.6 hours after a dose
Watch out for
Boxed warning for complex sleep behaviors (sleep-walking, sleep-driving and other activities while not fully awake) that have caused serious injuries and death. Next-morning impairment, including impaired driving, is more likely with less than 7 to 8 hours of sleep, higher doses, alcohol and other sedatives. Do not take it after drinking alcohol that evening.
What is it
Zolpidem is a prescription sleep medicine and a Schedule IV controlled substance. It was first approved in the US in 1992 and is sold as Ambien and generic tablets, as extended-release Ambien CR and as Edluar tablets that dissolve under the tongue. The FDA label approves Ambien for the short-term treatment of insomnia with trouble falling asleep, and Ambien CR for trouble falling or staying asleep. Zolpidem is not a benzodiazepine, but it acts on the same brain receptor. It carries a boxed warning for complex sleep behaviors: sleep-walking, sleep-driving and other activities while not fully awake, some of which have caused serious injuries and death. Alcohol and other sedating products are the main drink and supplement concerns.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
insomnia: time to fall asleep Good Evidence | Small; about 22 minutes faster sleep onset than placebo on sleep studies | Adults whose main problem is falling asleep | The first night |
insomnia disorder: sleep quality in acute treatment Good Evidence | Small to moderate in acute treatment; more side-effect dropouts than placebo | Adults with insomnia disorder needing short-term treatment | Acute treatment, usually measured over weeks |
chronic primary insomnia over 6 months (extended-release) Good Evidence | Large on patient ratings; 89.8% vs 51.4% said it helped them sleep at 12 weeks | Adults aged 18 to 64 with chronic primary insomnia | Measured every 4 weeks up to 24 weeks |
insomnia: time to fall asleep
- Effect
- Small; about 22 minutes faster sleep onset than placebo on sleep studies
- Best fit
- Adults whose main problem is falling asleep
- Time
- The first night
insomnia disorder: sleep quality in acute treatment
- Effect
- Small to moderate in acute treatment; more side-effect dropouts than placebo
- Best fit
- Adults with insomnia disorder needing short-term treatment
- Time
- Acute treatment, usually measured over weeks
chronic primary insomnia over 6 months (extended-release)
- Effect
- Large on patient ratings; 89.8% vs 51.4% said it helped them sleep at 12 weeks
- Best fit
- Adults aged 18 to 64 with chronic primary insomnia
- Time
- Measured every 4 weeks up to 24 weeks
Evidence for 3 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
insomnia: time to fall asleep
Disease adjunctA 2012 meta-analysis of the trial data submitted to the FDA for the Z-drugs (eszopiclone, zaleplon and zolpidem) included 13 randomized placebo-controlled trials with 4,378 adults. Z-drugs reduced the time to fall asleep on sleep studies by 22 minutes more than placebo (95% CI 11 to 33 minutes), and also shortened self-reported time to fall asleep. Effects were larger with higher doses, longer treatment and zolpidem. The authors called the drug effect small and of questionable clinical importance on its own, although placebo response added to it.
Bottom line: Zolpidem and related drugs help people fall asleep somewhat faster, by about 22 minutes on average.
insomnia disorder: sleep quality in acute treatment
Disease adjunctA 2022 network meta-analysis in the Lancet pooled 154 double-blind randomized trials with 44,089 adults with insomnia disorder. For acute treatment, zolpidem was among the drugs more effective than placebo for self-rated sleep quality (effects for this group ranged from a standardized mean difference of 0.36 to 0.83, with high to moderate certainty), and it beat melatonin, ramelteon and zaleplon (moderate to very low certainty). Zolpidem caused more dropouts due to side effects than placebo (odds ratio 1.79, moderate certainty). For long-term treatment, only eszopiclone and lemborexant were more effective than placebo (very low certainty), and zolpidem had more side-effect dropouts than placebo (very low certainty).
Bottom line: In short-term use zolpidem improves sleep quality more than placebo, at the cost of more side effects.
chronic primary insomnia over 6 months (extended-release)
Disease adjunctA 6-month randomized, double-blind trial gave 1,018 adults aged 18 to 64 with chronic primary insomnia extended-release zolpidem 12.5 mg (669 people) or placebo (349 people), taken as needed on 3 to 7 nights a week. At week 12, 89.8% on zolpidem versus 51.4% on placebo said it helped them sleep, and at week 24, 92.3% versus 59.7%. Self-reported sleep onset, total sleep and night-time waking also improved, and no rebound insomnia was seen in the first 3 nights after stopping. Outcomes were self-reported, and one author worked for the manufacturer.
Bottom line: Extended-release zolpidem taken on 3 to 7 nights a week kept helping sleep over 6 months in one large trial.
How it works
How to take it
What to track
Bottom line: A prescriber sets the dose; take it right before bed with a full night ahead, on an empty stomach, and never after drinking alcohol.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning: complex sleep behaviors, including sleep-walking, sleep-driving and engaging in other activities while not fully awake, may occur after taking zolpidem. Some of these events have caused serious injuries, including death. They can happen after the first or any later dose, with or without alcohol or other sedatives, and the label says to stop zolpidem immediately if one occurs.
Central nervous system depression and next-day impairment, including impaired driving, more likely with less than 7 to 8 hours of sleep, higher doses, alcohol, other sedatives or drugs that raise zolpidem levels; falls, especially in older adults
Severe allergic reactions including angioedema of the tongue, throat or larynx; abnormal thinking and behavior changes, hallucinations and delirium; worsening depression and suicidal thoughts in people with depression
Breathing suppression in people with compromised breathing, including sleep apnea and myasthenia gravis, or when taken with opioids; hepatic encephalopathy in people with liver failure; and dependence, abuse and withdrawal symptoms after a rapid dose decrease or abrupt stop
Who should avoid it
- Anyone who has had a complex sleep behavior after taking Ambien, and anyone allergic to zolpidem (contraindicated)
- People with severe liver impairment (the label says to avoid it), and people with sleep apnea, myasthenia gravis or other breathing problems, who need a prescriber's review first
- Children: safety and effectiveness are not established, and 7% of children with ADHD in a trial had hallucinations
- People with current or past alcohol or drug misuse, for whom the label advises extreme caution
Pregnancy & breastfeeding
Pregnancy: the label says newborns of mothers who used zolpidem late in the third trimester have had breathing problems and sedation, some needing breathing support, and that published data have not shown a clear link between zolpidem and major birth defects. Zolpidem crosses the placenta, and newborns exposed during pregnancy or labor should be watched for excess sleepiness, low muscle tone and breathing problems. Breastfeeding: zolpidem has been found in breast milk, and there are reports of excess sedation in breastfed infants. The label says infants should be watched for sedation, low muscle tone and breathing problems, and that a breastfeeding woman may consider pumping and discarding milk during treatment and for 23 hours after a dose.
Interactions
The Ambien label reports an additive harmful effect on psychomotor performance with alcohol, and warns that alcohol and other sedating substances add to central nervous system depression and raise the risk of next-day impairment. The label and Medication Guide say not to take zolpidem if you drank alcohol that evening or before bed. Treat sleep-walking, sleep-driving or slow breathing as an emergency.
The label says other central nervous system depressants increase the risk of CNS depression and next-day impairment, that opioids may increase the risk of breathing suppression, and that using zolpidem with other sedative-hypnotics at bedtime or in the middle of the night is not recommended. Doses of both may need adjusting, so your prescriber needs to know about every sedating medicine.
The Ambien label says St. John's wort, a CYP3A4 inducer, may decrease zolpidem blood levels and is not recommended with it. In 14 healthy men, 14 days of the herb lowered average zolpidem exposure by about 30%. Avoid the combination unless your prescriber advises it, never take extra zolpidem if it seems weaker, and ask before stopping the herb if you already take both.
In a randomized crossover study in 16 healthy adults aged 55 and older, prolonged-release melatonin alone did not impair performance, but adding it to zolpidem (single bedtime doses) made zolpidem's impairment of psychomotor and driving performance 1 and 4 hours after the dose, and of early memory recall, worse. The next morning there was no extra effect on psychomotor or driving performance, although the drop in memory recall was more pronounced, and there was no pharmacokinetic interaction. Tell your prescriber if you use melatonin, and ask whether you need both.
Valerenic acid from valerian enhances GABA-A receptors in lab studies, so valerian may add to zolpidem's drowsiness, and the zolpidem label warns that other CNS depressants increase the risk of CNS depression and next-day impairment. No published human study of valerian with zolpidem was found, and a review of valerian found no evidence of clinically relevant drug interactions. Treat valerian as a second sedative: it is sensible not to layer it on zolpidem, and ask your prescriber if zolpidem alone is not working.
Rifampin, a CYP3A4 inducer, significantly reduced zolpidem levels and effects, and the label says the combination is not recommended. Ketoconazole, a strong CYP3A4 blocker, increased zolpidem levels and effects, and the label suggests considering a lower zolpidem dose.
Cocoa contains small amounts of caffeine and larger amounts of theobromine; in a food analysis, chocolates had the lowest caffeine content of the foods tested. In 12 healthy men, 150 mg of caffeine at bedtime delayed sleep onset and shortened sleep, and adding zolpidem lessened the drop in sleep efficiency. An evening cup of hot chocolate is a minor issue for most people, but keeping caffeine sources away from bedtime is sensible.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (4)
+ alcohol
criticalZolpidem (Ambien) and alcohol both increase activity at the GABA-A receptor, producing additive sedation, impaired psychomotor performance, and an elevated risk of complex sleep behaviors, falls, and: at higher levels of intoxication, respiratory depression. The combination is an additive pharmacodynamic effect; the FDA interaction study found no change in zolpidem blood levels from alcohol.
+ st. john's wort
highSt. John's wort speeds up CYP3A4, a liver enzyme that helps clear zolpidem (Ambien), so it can lower zolpidem levels and weaken its effect on sleep. The Ambien label says using St. John's wort with zolpidem may decrease zolpidem blood levels and is not recommended. In 14 healthy men, 14 days of St. John's wort lowered zolpidem exposure by about 30% on average, although 3 of them showed a small increase; the study measured blood levels, not sleep.
+ melatonin
moderateZolpidem and melatonin are both used to help with sleep, so people sometimes take them together. In a controlled study of 16 healthy adults aged 55 and older, adding prolonged-release melatonin made zolpidem's impairment of coordination, driving and early memory recall worse at 1 and 4 hours after the dose, and the next-day drop in memory recall was more pronounced, although next-morning driving and coordination were not affected. Melatonin did not change zolpidem blood levels, so the effect is on the brain.
+ valerian
moderateZolpidem is a Z-drug hypnotic that acts on the GABA-A receptor, and valerian's valerenic acid boosts GABA-A receptors in lab studies, so the two may add to each other's drowsiness and next-day impairment. The zolpidem label warns that other CNS depressants increase the risk of CNS depression and that zolpidem should not be combined with other sedative-hypnotics at bedtime. No published human study of valerian with zolpidem was found, and a review of valerian found no clinically relevant effect on drug-clearing enzymes; the concern is the same added sedation as with valerian and benzodiazepines.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take melatonin with zolpidem?⌄
Ask your prescriber first. In a study of adults aged 55 and older, adding prolonged-release melatonin made zolpidem's impairment of coordination, driving and memory in the hours after the dose worse, although next-morning driving was not affected.
Can I take valerian with Ambien?⌄
It is sensible not to. Valerian may act on the same calming receptor, though a review found no clinically relevant valerian interactions and no published human study has tested it with zolpidem. If zolpidem alone is not working, raise it with your prescriber rather than adding herbs.
Can I drink alcohol and take zolpidem?⌄
No. The label reports an additive harmful effect on coordination with alcohol and says not to take zolpidem if you drank alcohol that evening or before bed.
Should I take zolpidem with food?⌄
No. Taking it with or right after a meal lowered and delayed peak levels in a label study, so it may work more slowly. The label says to take it on an empty stomach, right before bed.
Is it safe to drive the morning after taking zolpidem?⌄
Only if you had a full 7 to 8 hours in bed and feel fully alert. The label warns of next-day impairment, including impaired driving, especially with higher doses, less sleep, alcohol or other sedatives. Women clear zolpidem more slowly, which is why their starting dose is lower.
References by claim
insomnia: time to fall asleep
Huedo-Medina et al., 2012 · PMC (2012) link
insomnia disorder: sleep quality in acute treatment
De Crescenzo et al., 2022 · PubMed (2022) link
chronic primary insomnia over 6 months (extended-release)
Krystal et al., 2008 · PMC (2008) link
Safety
Ambien (zolpidem tartrate) prescribing information and Medication Guide · DailyMed (FDA label) link
Interaction: Melatonin
Otmani et al., 2008 · PubMed (2008) link
Interaction: Hot chocolate and cocoa drinks
Interaction: St. John's wort
Hojo et al., 2011 · PubMed (2011) link
Track Zolpidem with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
